Skip to main content
. 2021 Jun 17;13:645611. doi: 10.3389/fnagi.2021.645611

Table 3.

Paraclinical characteristics of patients.

Characteristics Non-elderly, N (%) Elderly, N (%) p-value
78 (52.7%) 70 (47.3%)
Hemoglobin, g/dL 13.9 (8, 17.4) 13.05 (5.7, 17.8) 0.007
Leukocytes, /μL 6,690 (2,700, 26,000) 8,060 (2,100, 20,500) 0.022
Neutrophils, /μL 4,125 (1,100, 23,400) 6,060 (1,400, 18,100) 0.003
Lymphocytes, /μL 1,670 (300, 4,000) 1,245 (400, 9,800) 0.001
Platelets, × 103 /μL 244.5 (47, 462) 205.5 (63, 460) 0.06
CRP, mg/L 5.72 (0.2, 222.2) 29.27 (0.3, 343.1) <0.001
Ferritin, μg/L 187 (12.9, 4,070) 482 (23, 10,538) <0.001
Fibrinogen, mg/dL 374 (117, 675) 477 (115, 907) <0.001
D-dimer 0.42 (0.2, 21) 1.16 (0, 21) <0.001
PT, s 13.8 (11.3, 26.9) 15.15 (12.2, 50.9) 0.001
aPTT, s 28.9 (7.1, 38.4) 29.5 (22.7, 53.5) 0.109
IL-6, pg/mL 28.9 (1.5, 989.6) 48.96 (5.9, 603.9) 0.293
AST, U/L 20.8 (11.2, 145.9) 26.8 (8.7, 121.8) 0.001
ALT, U/L 20.3 (2.8, 106.6) 21 (6.2, 107.9) 0.908
GGT, U/L 43 (7, 1,626) 46.5 (8, 530) 0.309
Creatinine, mg/dL 0.77 (0.2, 8.9) 0.96 (0.2, 4) <0.001
BUN, mg/dL 27.65 (0.6–104) 51.1 (13.7–139.1) <0.001
Sodium, mmol/L 140 (132, 149) 140 (126, 151) 0.846
Potassium, mmol/L 4.05 (3, 6.6) 3.96 (2.8, 5.8) 0.781
Pulmonary involvement, % 10 (0, 60) 25 (0, 80) <0.001
Viral positivity duration, days 15 (0, 51) 12 (0, 67) 0.575